Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care setting...
Baxter International Inc. (BAX) has a valuation score of 70/100 (moderate), profitability score of 24/100 (weak), financial health score of 78/100 (strong), Piotroski F-Score of 5/9, Altman Z-Score of 1.89 (grey zone), revenue growth of -9.4% YoY.
Neutral
Analyst Consensus
SellWall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026
Analyst Recommendations20 analysts · 2026-08-01
4
14
Strong Buy 1Buy 4Hold 14Sell 1Strong Sell 0
Recent Market Moves
See all BAX moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Aug 7 | Regular | $27.82 | +3.02% | 2.01 |
| Aug 5 | Regular | $27.36 | -3.51% | -2.34 |
| Aug 5 | After-hours | $27.36 | -3.49% | -2.33 |
| Aug 3 | Regular | $28.07 | +7.28% | 4.85 |
| Aug 3 | After-hours | $28.22 | +7.87% | 5.25 |